{"id":47800,"date":"2026-08-07T07:08:00","date_gmt":"2026-08-07T07:08:00","guid":{"rendered":"http:\/\/7fd323d1-610c-47d0-94cf-f76585784e81"},"modified":"2026-11-03T07:01:11","modified_gmt":"2026-11-03T07:01:11","slug":"ema-recommends-extension-of-indications-for-ponatinib-associated-with-a-new-pharmaceutical-form-and-a-new-strength","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/ema-recommends-extension-of-indications-for-ponatinib-associated-with-a-new-pharmaceutical-form-and-a-new-strength\/","title":{"rendered":"EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength"},"content":{"rendered":"<p>New indication concerns a monotherapy in paediatric patients with CP-CML who are resistant or intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate or who have the <em>T315I<\/em> mutation<\/p>\n<p><a href=\"https:\/\/www.esmo.org\/oncology-news\/ema-recommends-extension-of-indications-for-ponatinib-associated-with-a-new-pharmaceutical-form-and-a-new-strength\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>New indication concerns a monotherapy in paediatric patients with CP-CML who are resistant or intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate or who have the T315I mutation Source<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-47800","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/47800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=47800"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/47800\/revisions"}],"predecessor-version":[{"id":47974,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/47800\/revisions\/47974"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=47800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=47800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=47800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}